Description
BSE announces changes to the Short Term 5/15/30 Days ASM Framework effective March 05, 2026, including new additions, stage movements, and securities moving out of the framework.
Summary
BSE has issued an update to the Short Term (ST) Additional Surveillance Measure (ASM) framework effective March 05, 2026. The circular details securities newly added to the ST 5/15/30 Days ASM Framework, securities moving to higher or lower ASM stages, and securities exiting the framework. A consolidated list of all securities currently under ST-ASM is also provided.
Key Points
- 3 new securities added to ST-ASM Framework (Stage I) effective March 05, 2026
- 1 security (Yajur Fibres Ltd) moved to a higher ASM stage within the ST framework
- No securities moved to a lower ASM stage
- 10 securities removed from the ST-ASM Framework, with some moving to LT-ASM or ESM frameworks
- SME scrips are specifically marked with ‘@’ throughout the circular
- Securities marked ‘*’ are moving out due to inclusion in the LT-ASM Framework
- Securities marked ‘$’ are moving out due to inclusion in the ESM Framework
Regulatory Changes
Newly Added to ST-ASM (w.e.f. March 05, 2026):
- Enbee Trade & Finance Ltd (Scrip Code: 512441, ISIN: INE993I01029)
- Siddha Ventures Ltd (Scrip Code: 530439, ISIN: INE140C01012)
- Supha Pharmachem Ltd (Scrip Code: 539561, ISIN: INE549S01036)
Moving to Higher Stage (w.e.f. March 05, 2026):
- Yajur Fibres Ltd@ (Scrip Code: 544676, ISIN: INE0CNJ01010) — SME scrip
Moving to Lower Stage: NIL
Exiting ST-ASM Framework (w.e.f. March 05, 2026):
- Alacrity Securities Ltd (535916)
- Anuroop Packaging Ltd (542865)
- Avanti Feeds Ltd (512573) — moving to LT-ASM
- Novartis India Ltd (500672)
- VL E-Governance & IT Solutions Ltd (543958)
- Dipna Pharmachem Ltd@ (543594) — SME scrip
- Integrated Proteins Ltd* (519606) — moving to LT-ASM
- Zelio E Mobility Ltd@* (544563) — SME scrip, moving to LT-ASM
- Lippi Systems Ltd$ (526604) — moving to ESM
- Akme Fintrade (India) Ltd$ (544200) — moving to ESM
Compliance Requirements
- Brokers and trading members must update their systems to apply the revised ST-ASM framework from March 05, 2026
- Applicable trading restrictions (price bands, margin requirements) under ST-ASM stages must be enforced for all listed securities in the consolidated list
- Investors holding or trading in affected securities should note the revised surveillance status and associated trading conditions
Important Dates
- Effective Date: March 05, 2026 — All additions, stage changes, and removals take effect
- Circular Date: March 04, 2026
Impact Assessment
The ST-ASM framework imposes enhanced surveillance and trading restrictions on shortlisted securities, typically including additional margin requirements and price band limitations. The addition of 3 securities increases regulatory oversight on those counters, potentially reducing liquidity and increasing trading costs for participants. The removal of 10 securities generally eases trading conditions for those counters, though two of these (Avanti Feeds, Integrated Proteins, Zelio E Mobility) are moving to the stricter LT-ASM framework, and two (Lippi Systems, Akme Fintrade) to ESM, indicating continued elevated surveillance. Overall, this circular reflects routine periodic review of market surveillance measures across BSE-listed securities.
Impact Justification
Directly affects trading conditions for multiple securities by adding new ones to ST-ASM, moving securities between stages, and removing others; impacts investor decisions and trading strategies across several listed companies.